Group 1: Share Buyback Progress - As of November 30, 2025, the company has repurchased a total of 9.3199 million shares, utilizing a total fund of 247 million yuan [1] - The company initially planned to use between 500 million yuan and 1 billion yuan for share repurchase, with the repurchased shares intended for cancellation to reduce registered capital [1] - The company has significantly raised the upper limit of the repurchase price from 19.36 yuan per share to 75 yuan per share, nearly tripling the previous limit to boost investor confidence [1] Group 2: Dividend Distribution - The company has proposed a cash dividend plan for the first half of 2025, amounting to a total cash dividend of 6.55 billion yuan, which was approved by the shareholders' meeting [2] - To date, the company has completed seven cash dividend distributions, totaling 56.54 billion yuan, maintaining its position as the top dividend payer in the A-share electronic industry for many years [2]

格隆汇12月1日丨维信诺(002387.SZ)公布，截至2025年11月30日，公司通过回购专用证券账户以集中竞 价交易方式回购公司股份，累计回购股份数量为1,660,700股，约占公司总股本的0.12%，最高成交价为 9.11元/股，最低成交价为8.75元/股，支付总金额为14,999,460元（不含交易费用）。本次回购符合法律 法规、规范性文件的有关规定及公司回购股份方案的要求。 ...

格隆汇12月1日丨歌尔股份(002241.SZ)公布，公司于2025年4月11日首次通过回购专用证券账户以集中 竞价交易方式实施本次回购股份。截至2025年11月30日，公司通过回购专用证券账户使用自有资金和自 筹资金以集中竞价交易方式累计回购股份34,497,046股，占公司总股本的比例为0.97%，最高成交价为 34.09元/股，最低成交价为20.35元/股，支付金额为950,080,648.62元（不含交易费用）。 ...

领益智造公告称，公司于2025年4月11日通过回购股份议案，资金总额不低于2亿元、不超4亿元，回购 价不超13.18元/股。因2024年度及2025年半年度利润分配，回购价格上限调整为不超13.14元/股。截至 11月30日，公司累计回购38,231,900股，占总股本的0.52%，最高成交价8.55元/股，最低成交价8.06元/ 股，成交金额3.20亿元，资金来自自有资金及专项贷款。后续将继续实施回购并及时披露。 ...

九安医疗12月1日公告，公司于2025年10月13日召开了第六届董事会第二十七次会议，审议并通过了 《关于公司回购股份方案的议案》。本次回购资金来源为公司自有资金及回购专项贷资金，回购的资金 总额不低于3亿元（含）且不超过6亿元（含），回购股份的价格为不超过53.5元/股（含）。截至2025 年11月30日，公司累计回购1056.63万股，占公司总股本的2.27%，回购价格区间为39.598元/股至41.6元/ 股，累计使用资金4.25亿元（不含交易费用）。 ...

Group 1: Share Buyback Progress - As of November 30, 2025, the company has repurchased a total of 9.3199 million shares, utilizing a total fund of 247 million yuan [1] - The company initially planned to use between 500 million yuan and 1 billion yuan for share repurchase, with the repurchased shares intended for cancellation to reduce registered capital [1] - The company has significantly raised the upper limit of the repurchase price from 19.36 yuan per share to 75 yuan per share, nearly tripling it, to boost investor confidence [1] Group 2: Dividend Distribution - The company has proposed a cash dividend plan for the first half of 2025, amounting to a total cash dividend of 6.55 billion yuan, which has been approved by the shareholders' meeting [2] - To date, the company has completed seven cash dividend distributions, totaling 56.54 billion yuan, maintaining its position as the top dividend payer in the A-share electronic industry for many years [2]

中远海发公告称，公司于2025年8月30日首次披露回购方案，预计回购金额1.52亿元-3.05亿元，回购股 份4000万股-8000万股，用途为减少注册资本。回购实施期限自公司股东会审议通过至2025年年度股东 会结束（预计2026年6月30日）。截至2025年11月30日，公司已累计回购600万股，占总股本的 0.0455%，支付总金额1577.74万元，回购价格2.53元/股-2.71元/股。 ...

Core Viewpoint - Weichai Power announced a share buyback plan, indicating a commitment to returning value to shareholders through repurchase of shares [1] Summary by Categories Share Buyback Details - As of November 30, 2025, the company has repurchased a total of 50.2525 million shares, which represents 0.58% of the total share capital [1] - The buyback price ranged from 14.57 CNY per share to 15.43 CNY per share [1] - The total funds used for the buyback amounted to 761 million CNY, excluding transaction costs [1]

Core Viewpoint - Chenhua Co., Ltd. (300610.SZ) has announced a share buyback program, indicating a commitment to returning value to shareholders through repurchasing shares in the market [1] Summary by Categories Share Buyback Details - As of November 30, 2025, the company has repurchased a total of 2,046,500 shares, which represents 0.9518% of the total share capital [1] - The highest transaction price during the buyback was 12.25 CNY per share, while the lowest was 10.85 CNY per share [1] - The total amount spent on the share buyback reached 23,331,582 CNY [1]

格隆汇12月1日丨丽珠医药(01513.HK)发布公告，截至2025年11月30日，公司通过集中竞价交易方式回 购了公司A股股份共计1619.33万股，占公司总股本的比例为1.79%，购买的最高价为人民币41.99元/ 股，最低价为人民币33.21元/股，已使用的资金总额为人民币6.002亿元(不含交易费用)。 ...